Travere Therapeutics (TVTX) Other Non Operating Income (2016 - 2025)
Historic Other Non Operating Income for Travere Therapeutics (TVTX) over the last 13 years, with Q3 2025 value amounting to $487000.0.
- Travere Therapeutics' Other Non Operating Income fell 634.62% to $487000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$71000.0, marking a year-over-year increase of 9479.09%. This contributed to the annual value of -$3.3 million for FY2024, which is 30815.56% down from last year.
- Latest data reveals that Travere Therapeutics reported Other Non Operating Income of $487000.0 as of Q3 2025, which was down 634.62% from -$526000.0 recorded in Q2 2025.
- In the past 5 years, Travere Therapeutics' Other Non Operating Income ranged from a high of $1.4 million in Q4 2023 and a low of -$7.6 million during Q1 2022
- Its 5-year average for Other Non Operating Income is -$448166.7, with a median of $162500.0 in 2023.
- As far as peak fluctuations go, Travere Therapeutics' Other Non Operating Income soared by 47748.69% in 2021, and later plummeted by 163880.6% in 2024.
- Travere Therapeutics' Other Non Operating Income (Quarter) stood at -$860000.0 in 2021, then soared by 31.86% to -$586000.0 in 2022, then skyrocketed by 334.47% to $1.4 million in 2023, then tumbled by 142.29% to -$581000.0 in 2024, then surged by 183.82% to $487000.0 in 2025.
- Its Other Non Operating Income was $487000.0 in Q3 2025, compared to -$526000.0 in Q2 2025 and $549000.0 in Q1 2025.